NEW ENTERPRISE ASSOCIATES 13 LP 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-30 7:31 pm Sale | 2024-04-30 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | NEW ENTERPRISE ASSOCIATES 13 LP | 0 0.000% | -92,909,956 (Position Closed) | Filing |
| 2023-03-28 6:51 pm Purchase | 2023-03-02 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | NEW ENTERPRISE ASSOCIATES 13 LP | 92,909,956 5.100% | 88,000,000 (+1792.28%) | Filing |